A Safety Study of Carfilzomib in Patients With Previously-Treated Systemic Light Chain Amyloidosis

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2016 by Academic Myeloma Consortium
Sponsor:
Collaborators:
Onyx Pharmaceuticals
Criterium, Inc.
Information provided by (Responsible Party):
Academic Myeloma Consortium
ClinicalTrials.gov Identifier:
NCT01789242
First received: February 6, 2013
Last updated: January 4, 2016
Last verified: January 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2017
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)